Las Vegas Mobile IV
US$ 26.48
companies developing glp-1 drugs GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ companies developing glp-1 drugs Beyond
Description
10.1056/NEJMoa1411892 34
Appetite was now a commodity, and the market couldnt move fast enough
Insurance Claim With medical bills and inflation on the rise, insurance coverage is a key factor for many patients who are considering these routes for weight loss or disease management
Clinical trials show average weight loss of 14.9% over 68 weeks
Risk of bias was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using GRADE
Look ARG, Wing RR, Bolin P, et al
